Search Results
Slidesets
Oral Abstract Presentation #6 | Enagnon Kazali Alidjinou
Presented at:
European Meeting on HIV & Hepatitis 2024
Slidesets
Resistance Considerations in Choosing PrEP Across Europe | Anna Maria Geretti
Presented at:
European Meeting on HIV & Hepatitis 2024
Slidesets
Clinical Considerations: What Have We Learned? - Fiona Cresswell, PhD, MBChB, BSc, DTM&H, PGCert Epi, DipHIV
Presented at:
Innovations in HIV Therapeutics 2022 - Asia-Pacific Edition
Slidesets
Comorbidity and Toxicity Considerations in Choice of Regimen Photo - Esteban Martínez, MD, PhD
Presented at:
European HIV Clinical Forum 2022
Slidesets
Strategies to Vaccinate Immunocompromised Patients - Anna Maria Geretti, MD, PhD, FRCPath
Presented at:
International Workshop on COVID-19 Vaccines 2022 - June Edition
Slidesets
Low-Level of Archived Resistance to Integrase Inhibitors Among Third-Line Patients...Future Therapeutics - Ezechiel Ngoufack Jagni Semengue
Presented at:
INTEREST 2022
Slidesets
Acute COVID 19 and predictors of outcome - Lloyd Mulenga
Presented at:
Approaches to Combat COVID-19 in Low- and Middle-Income Countries Workshop
Slidesets
Role of Integrase Inhibitors in the clinical care of HIV infected pregnant women and adolescents- Thanyawee Puthanakit, MD
Presented at:
Asia-Pacific HIV Clinical Forum 2018
Slidesets
Co-Administration of Pretomanid with Rifampin or Rifabutin Among Patients with Pulmonary TB: Interim PK Results from “Assessing Pretomanid for Tuberculosis” (APT) Trial - Elisa Ignatius
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2019